Bőrgyógyászati témájú publikációink 2014-19: 21 db

  1. Rencz F, Gulácsi L, Péntek M, Szegedi A, Remenyik É, Bata-Csörgő Z, Bali G, Hidvégi B, Tamási B, Poór AK, Hajdu K, Holló P, Kinyó Á, Sárdy M, Brodszky V. (2019) DLQI-R scoring improves the discriminatory power of Dermatology Life Quality Index in psoriasis, pemphigus and morphea patients. Br J Dermatol. 2019 Aug 16. doi: 10.1111/bjd.18435. [Epub ahead of print] IF(2018) 6.714
  2. Hajdu K, Brodszky V, Stalmeier PFM, Ruzsa G, Tamási B, Gulácsi L, Péntek M, Sárdy M, Bata-Csörgő Z, Kinyó Á, Szegedi A, Rencz F. (2019) Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol. 2019 Jul 2. doi: 10.1111/jdv.15765. [Epub ahead of print] IF(2018) 5.113
  3. Tamási B, Brodszky V, Péntek M, Gulácsi L, Hajdu K, Sárdy M, Szegedi A, Bata-Csörgő Z, Kinyó Á, Rencz F. (2019) Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. 180(4):802-809. IF(2018) 6.714
  4. Mitev A, Rencz F, Tamási B, Hajdu K, Péntek M, Gulácsi L, Szegedi A, Bata-Csörgő Z, Kinyó Á, Sárdy M, Brodszky V. (2019) Subjective well-being in patients with pemphigus: a path analysis. Eur J Health Econ. 20(Suppl 1):101-107. IF(2018) 2.169
  5. Poór AK, Péntek M, Rencz F, Sárdy M, Holló P, Hidvégi B, Tamási B, Bali G,Remenyik É, Szegedi A, Bata-Csörgő Z, Kinyó Á, Kárpáti S. (2019) Az életminőség mérése a bőrgyógyászatban: hazai tapasztalatok. BŐRGYÓGYÁSZATI ÉS VENEROLÓGIAI SZEMLE, 95(3):100-107.
  6. Rencz F, Brodszky V, Gulácsi L, Péntek M, Poór AK, Holló P, Szegedi A, Remenyik É, Sárdy M, Langenbruch A, Radtke MA, Gutknecht M, Augustin M. (2019) Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 33(7):e267-e269. IF(2018) 5.113
  7. Rencz F, Gulacsi L, Pentek M, Poor AK, Sardy M, Hollo P, Szegedi A, Remenyik E, Brodszky V. (2018) Proposal of a new scoring formula for the DLQI in psoriasis. Br J Dermatol 179(5):1102-1108. IF 6.714
  8. Rencz F, Poor AK, Pentek M, Hollo P, Karpati S, Gulacsi L, Szegedi A, Remenyik E, Hidvegi B, Herszenyi K, Jokai H, Beretzky Z, Brodszky V (2018) A detailed analysis of ‘not relevant’ responses on the DLQI in psoriasis: potential biases in treatment decisions. Journal of the European Academy of Dermatology and Venereology 32:(5) 783-790. IF 5.113
  9. Bali G, Karpati S, Sardy M, Brodszky V, Hidvegi B*, Rencz F* (2018) Association between quality of life and clinical characteristics in patients with morphea. Quality of Life Research. 27(10):2525-2532. IF 2.488
  10. Poor AK, Brodszky V, Pentek M, Gulacsi L, Ruzsa G, Hidvegi B, Hollo P, Karpati S, Sardy M, Rencz F. (2018) Is the DLQI appropriate for medical decision-making in psoriasis patients? Archives of Dermatological Research 310(1):47-55. IF 2.309
  11. Poór AK, Sárdy M, Cserni T, Brodszky V, Holló P, Gulácsi L, Remenyik É, Szegedi A, Rencz F, Péntek M. (2018) [Assessment of health-related quality of life in psoriasis patients in Hungary]. Orv Hetil. 159(21):837-846. [In Hungarian]IF 0.564
  12. Poór AK, Rencz F, Brodszky V, Gulácsi V, Beretzky Z, Hidvégi B, Holló P, Kárpáti S, Péntek M (2017) Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients, Quality of Life Research. 26(12):3409-3419. IF 2.392
  13. Rencz F, Brodszky V, Stalmeier PFM, Tamási B, Kárpáti S, Péntek M, Baji P, Mitev AZ, Gulácsi L. (2016) Valuation of pemphigus vulgaris and foliaceus health states: a convenience sample experiment. British Journal of Dermatology 175(3):593-9. IF 4.706
  14. Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. (2016) Alopecia areata and health-related quality of life: a systematic review and meta-analysis. British Journal of Dermatology 175(3):561-71.  IF 4.706
  15. Rencz F, Baji P, Gulácsi L, Kárpáti S, Péntek M, Poór AK, Brodszky V (2016) Discrepancies between the Dermatology Life Quality Index and utility scores. Quality of Life Research, 25(7):1687-96.  IF 2.344
  16. Rencz F, Kemény L, Gajdácsi JZ, Owczarek W, Arenberger P, Tiplica GS, Stanimirović A, Niewada M, Petrova G, Marinov LT, Péntek M, Brodszky V, Gulácsi L. (2015) Use of biologics for psoriasis in Central and Eastern European countries. Journal of the European Academy of Dermatology and Venereology 29(11):2222-30. IF 3.029
  17. Rencz F, Gulácsi L, Tamási B, Kárpáti S, Péntek M, Baji P, Brodszky V. (2015) Health related quality of life and its determinants in pemphigus: a systematic review and meta-analysis. British Journal of Dermatology 173(4):1076-80. IF 4.317
  18. Rencz F, Hollo P, Karpati S, Pentek M, Remenyik E, Szegedi A, Balogh O, Herédi E, Herszényi K, Jókai H, Brodszky V, Gulácsi L. (2015) Moderate to severe psoriasis patients’ subjective future expectations regarding health-related quality of life and longevity. Journal of the European Academy of Dermatology and Venereology 29(7):1398-405. IF 3.029
  19. Heredi E, Rencz F, Balogh O, Gulacsi L, Herszenyi K, Hollo P, Jokai H, Karpati S, Pentek M, Remenyik E, Szegedi A, Brodszky V. (2014) Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. Eur J Health Econ. 15 Suppl 1:S111-9. IF 1.774
  20. Balogh O, Brodszky V, Gulácsi L, Herédi E, Herszényi K, Jókai H, Kárpáti S, Baji P, Remenyik É, Szegedi A, Holló P. (2014) Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres. Eur J Health Econ. 2014 May;15 Suppl 1:S101-9. IF 1.774
  21. Rencz F, Brodszky V, Péntek M, Balogh O, Remenyik E, Szegedi A, Holló P, Kárpáti S, Jókai H, Herszényi K, Herédi E, Szántó S, Gulácsi L. (2014) Disease burden of psoriasis associated with psoriatic arthritis in Hungary. Orv Hetil. 155(48):1913-21.